Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature.

Miguel Ángel ElorriagaJosé Luis NeyroJon MiezaIgnacio Cristóbal Antoni Llueca

Published in: Journal of personalized medicine (2021)

The usefulness of the tumour markers antigen CA125 and antigen HE4 individually or as a basis for decision-making algorithms has low specificity; however, there is little evidence that confirms their usefulness as markers in ovarian cancer screening.

Keyphrases

decision making
machine learning
deep learning
protein kinase